Launch of first product in Australia

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com



FOR PUBLIC RELEASE
NZX Limited
Wellington

5
th
September 2023

FOR IMMEDIATE RELEASE

Rua Bioscience launches first product in Australia


Rua Bioscience positioned for growth, establishing collaborative networks and seizing
opportunity in the booming Australian cannabis market.


Rua Bioscience, a New Zealand-based leader in the medicinal cannabis sector, today announced
its official entry into the dynamic Australian medicinal cannabis market. Teaming up with Anspec,
a leading pharmaceutical distribution company, Rua Bioscience product is now available to
Australian patients through prescribers.

In 2022, the Australian cannabis market was valued at A$240 million per year
(1)
.

“This launch marks a momentous step forward in Rua Bioscience's commitment to the thriving
Australian market,” said Chief Executive Officer Paul Naske. “The further substantial growth of the
market since 2022 underscores the tremendous potential it holds, with strong demand for
differentiated products.”

Rua Bioscience’s dedicated Medical Science Liaison has been actively engaging with prescribers,
to facilitate informed and responsible usage of the product.

"Our interactions with Australian doctors and clinics are a testament to our commitment to
collaboration and reducing some of the barriers to prescribing," said Jessika Buscke, Medical
Science Liaison.

"By connecting with prescribers, we can ensure that our product is integrated responsibly into
patient care plans, thereby contributing to optimal health outcomes."

This partnership-driven approach not only ensures responsible product usage. It also positions
Rua Bioscience for sustained growth and expansion.

“We recognise the strategic value of these collaborations in establishing a robust pipeline for
bringing our unique cannabis varieties from Ruatorea on the East Coast of New Zealand to the
Australian market,” said Mr Naske. "We’re essentially connecting the East Coast of New Zealand
with the East Coast of Australia.


GENERAL ANNOUNCEMENT

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com



“This is a pivotal moment in our journey, and Rua Bioscience is well-positioned to navigate the
evolving landscape of the Australian medicinal cannabis market. The entry into the Australian
market, and the launch of our products, marks the establishment of another network that will
ultimately make positive, long-term impacts back home in NZ in our communities of Ruatorea
and Tairāwhiti.”

For more information about Rua Bioscience please visit www.ruabioscience.com.


ENDS


The person who authorised this announcement:
Paul Naske,
Chief Executive Officer

For shareholder enquiries please visit www.ruabio.com or contact:
info@ruabio.com
0800 RUABIO


Source:
(1) - Pennington Institute Australia, May 2023 https://www.youtube.com/watch?v=3FtzL4QerCM